MGI Virtual Xpert: Introduction to DNBSEQ-G50: Compact and flexible benchtop sequencer

Aug 26, 2023

Share article

#MGI Virtual Xpert - our new learning centre, localised all educational resources, technologies, and application areas.

MGI Virtual Xpert: Introduction to DNBSEQ-G50: Compact and flexible benchtop sequencer
MGI Virtual Xpert: Introduction to DNBSEQ-G50: Compact and flexible benchtop sequencer
MGI Virtual Xpert: Introduction to DNBSEQ-G50: Compact and flexible benchtop sequencer

DNBSEQ-G50: Revolutionizing Genetic Sequencing with Efficiency and Flexibility

Advancements in Life Science Innovation

Focusing on the biotech industry, MGI specializes in R&D, production and sales of equipment and instruments, reagents, and related products to support life science research in a wide range of frontier applications, including precision medicine, precision agriculture, precision healthcare, and more. At MGI, we are working on the improvement of the availability of genomic technologies by providing customers with core tools for life science research and applications.

MGI Patented DNBSEQ™ Technology  – Enhancing Accuracy

DNBSEQ™ provides the advantages of low amplification error rates from DNBs and high-density Patterned Arrays to significantly improve the accuracy of sequencing with a low repetition rate.

Combined with the PCR-free library preparation approach, it reduces the error of entry during amplification and greatly improves the accuracy of detecting SNPs and indels.

The compact and flexible benchtop sequencer  DNBSEQ-G50 empowers flexibility and creates a perfect balance between speed and affordability. Offering different read length options for two different flow cell types, it can support a wide range of research and clinical applications.

Watch the new episode of #MGI Virtual Xpert to learn more about DNBSEQ-G50:

Enhance your daily sequencing capabilities with DNBSEQ-G50

DNBSEQ-G50 is a compact and flexible benchtop genetic sequencer. The design of two different flowcells empowers flexibility and creates a perfect balance between speed and affordability. FCS (Flow Cell Small) allows short turnaround time for short turnaround time (STAT) samples, and FCL (Flow Cell Large) enables lower cost per sample.

DNBSEQ-G50 offers 3-4 read length options for both FCS and FCL, which support a wide range of research and clinical applications such as low-pass whole genome sequencing, targeted sequencing, small whole genome sequencing, RNA sequencing and whole exome sequencing, etc.

  • Output:  10~- 150 Gb per run

  • Flow cells: 75-100M (FCS), 500M (FCL)

  • Read Length: SE50, SE100, PE100, PE150

  • Applications: Small whole genome sequencing, targeted DNA/RNA panels, low-pass whole genome sequencing

About MGI

MGI Tech Co., Ltd. (MGI) is at the forefront of global innovation, actively contributing to life science through intelligent innovation. With a presence in over 100 countries and a customer base of 2600+, MGI's cutting-edge technology has been instrumental in the development of 736+ user patents, facilitating the creation of over 150 petabytes of data. The company's extensive portfolio includes sequencing instruments, automation instruments, reagents, and related products that cater to various sectors such as life science research, agriculture, precision medicine, and healthcare.

MGI is dedicated to advancing life science tools for the healthcare of the future. As of December 2021, the company's global presence has expanded to more than 100 countries and regions, serving over 1,300 international clients. With a workforce of over 2,900 professionals worldwide, including 5 centers for research and development and production facilities in Europe, MGI is committed to fostering innovation. Approximately 35% of MGI's employees are engaged in R&D, underscoring the company's focus on pioneering advancements in the field.

The impact of MGI's work is further evidenced by the publication of over 6,800 papers in prestigious scientific journals, showcasing the significant contribution of MGI's technology to the scientific community and beyond.

For more information about MGI and its contributions to life science and healthcare, please visit the MGI website or connect with us on Twitter, LinkedIn, or YouTube.

MGI

SEQUENCING

GENOME SEQUENCERS

DNBSEQ-G50

Share this article :

Share

More Science

Smart-seq3Xpress: a scalable, high-sensitivity and low-cost Single cell Full-length RNA-seq methodology.
Smart-seq3Xpress: a scalable, high-sensitivity and low-cost Single cell Full-length RNA-seq methodology.
Smart-seq3Xpress: a scalable, high-sensitivity and low-cost Single cell Full-length RNA-seq methodology.
Smart-seq3Xpress: a scalable, high-sensitivity and low-cost Single cell Full-length RNA-seq methodology.

Mar 5, 2024

Smart-seq3Xpress: a scalable, high-sensitivity and low-cost Single cell Full-length RNA-seq methodology.

Revolutionizing single-cell RNA-seq, SMART-seq3Xpress offers unparalleled sensitivity and cost-efficiency with full-length coverage.

Single-cell Spatial transcriptomics (sc-StereoSeq), opening a new era in plants and crops biology.
Single-cell Spatial transcriptomics (sc-StereoSeq), opening a new era in plants and crops biology.
Single-cell Spatial transcriptomics (sc-StereoSeq), opening a new era in plants and crops biology.
Single-cell Spatial transcriptomics (sc-StereoSeq), opening a new era in plants and crops biology.

Jan 10, 2024

Single-cell Spatial transcriptomics (sc-StereoSeq), opening a new era in plants and crops biology.

Explore how sc-StereoSeq is transforming our understanding of plant biology, from crop production to plant stress responses, marking a new era in spatial transcriptomics.

Can Next-generation Sequencing accelerate mRNA vaccine development?
Can Next-generation Sequencing accelerate mRNA vaccine development?
Can Next-generation Sequencing accelerate mRNA vaccine development?
Can Next-generation Sequencing accelerate mRNA vaccine development?

Oct 10, 2023

Can Next-generation Sequencing accelerate mRNA vaccine development?

Explore the transformative impact of Next-Generation Sequencing in mRNA vaccine development. Dive into Nobel-winning discoveries, challenges, and novel technologies like the VAX-seq workflow, enhancing vaccine production, safety, and quality analysis amidst global health crises.

Join our newsletter to stay up to date on features and releases.

I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.

Join our newsletter to stay up to date on features and releases.

I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.

Join our newsletter to stay up to date on features and releases.

I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.